News

12/10/2017

European medicines agency must protect vulnerable clinical trial participants

In a letter to the director of the European Medicines Agency (EMA), three Members of European Parliament (MEPs) have expressed their concerns about vulnerable clinical trial participants in low- and middle-income countries. Read more

News

5/10/2017

European Parliament rejects criteria endocrine-disrupting chemicals

The European Parliament has rejected the European Commission’s proposed criteria for identifying endocrine-disrupting chemicals. These criteria, in their current form, would not sufficiently protect our health. Read more

News

28/9/2017

EU criteria for endocrine-disrupting chemicals will not protect health

The European Commission’s proposed criteria for identifying endocrine-disrupting chemicals should be amended, as they will not protect the health of European citizens. Read more

News

13/9/2017

Action plan for sustainable health workforce policy in European region

the 67th session of European member states of the World Health Organization (WHO). In a statement that she delivered on behalf of Medicus Mundi International (MMI), Wemos global health advocate Linda Mans stressed that without investments in health workforce, guaranteeing health security and universal access to health will be an impossible task. Read more

Blog

24/7/2017

We cannot allow this plan to fail: invest in health workforce

With changing lifestyles and ageing population, chronic diseases have become increasingly common. Bearing this in mind, it has been predicted that by the year 2030, there will be a demand for 40 million new jobs in healthcare worldwide, most of these in high-income countries. In this same period, the shortage of health workforce in low-income countries will have grown to 18 million. Read more

News

4/7/2017

Unethical clinical trials in Africa

Clinical trials in Africa are not always conducted according to leading ethical guidelines. This puts clinical trial participants at risk of being physically harmed or having their rights violated. Read more

Blog

22/6/2017

A Tanzanian view on the health workforce crisis

At Wemos we believe in evidence-based advocacy. This also means keeping in touch with people who work on the ground and hearing their stories. During the 70th World Health Assembly in May 2017, Paul Nedermeijer and I had the opportunity to work with the People’s Health Movement (PHM) and the WHO Watch team. Among the group was Godfrey Philimon, a highly motivated Tanzanian public health advocate. I interviewed him about his perspectives on the human resources for health situation in Tanzania. Read more

Statement chemical/ statement chemicaliën

News

30/5/2017

Precautionary principle should be aspplied to chemicals

At the 70th World Health Assembly in Geneva, Wemos delivered a statement on the roadmap on chemical management in collaboration with Medicus Mundi International and the People’s Health Movement. Read more

News

3/5/2017

EU parliament wants ethically tested drugs for EU market

On April 27th, the European Parliament voted in favour of a report which contained an amendment on the European Medicines Agency (EMA). The report states that the EMA must annually report its actions to ensure that drugs intended for the European market are tested ethically in lower- and middle-income countries. Read more